GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 281 filers reported holding GW PHARMACEUTICALS PLC in Q4 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $52,780,000 | -16.5% | 542,164 | +5.3% | 0.27% | -34.5% |
| Q2 2020 | $63,177,000 | +858.2% | 514,806 | +583.8% | 0.41% | +663.0% |
| Q1 2020 | $6,593,000 | -89.7% | 75,283 | -87.7% | 0.05% | -84.0% |
| Q4 2019 | $64,217,000 | -38.7% | 614,168 | -32.6% | 0.34% | -47.5% |
| Q3 2019 | $104,796,000 | -9.3% | 911,035 | +35.9% | 0.64% | +6.4% |
| Q2 2019 | $115,589,000 | +1881.0% | 670,511 | +1837.0% | 0.60% | +2226.9% |
| Q1 2019 | $5,835,000 | -81.1% | 34,616 | -89.1% | 0.03% | -82.7% |
| Q4 2018 | $30,796,000 | +111.7% | 316,216 | +275.6% | 0.15% | +150.0% |
| Q3 2018 | $14,545,000 | -26.1% | 84,200 | -40.3% | 0.06% | -24.1% |
| Q2 2018 | $19,689,000 | -51.9% | 141,100 | -61.2% | 0.08% | -53.8% |
| Q1 2018 | $40,933,000 | -22.8% | 363,300 | -9.6% | 0.17% | -25.3% |
| Q4 2017 | $53,024,000 | +230.0% | 401,665 | +153.7% | 0.23% | +218.1% |
| Q3 2017 | $16,070,000 | +20.7% | 158,343 | +19.2% | 0.07% | -4.0% |
| Q2 2017 | $13,313,000 | +158.4% | 132,800 | +211.7% | 0.08% | +158.6% |
| Q1 2017 | $5,152,000 | +55.7% | 42,600 | +43.9% | 0.03% | +26.1% |
| Q4 2016 | $3,308,000 | -83.7% | 29,600 | -80.6% | 0.02% | -83.8% |
| Q3 2016 | $20,263,000 | -44.7% | 152,663 | -70.0% | 0.14% | -49.5% |
| Q1 2016 | $36,663,000 | +1792.8% | 508,143 | +1721.3% | 0.28% | +1656.2% |
| Q4 2015 | $1,937,000 | – | 27,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|